Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Month, Open Label Study of Extended Release Tacrolimus (Envarsus XR®, LCPT) With Mycophenolate, Rabbit Antithymocyte Globulin (rATG) and Early Steroid Withdrawal in de Novo Kidney Transplant Recipients

NCT03828682 is registered in ClinicalTrials.gov with Simon Tremblay, PharmD, PhD as lead sponsor.

NCT NCT03828682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03828682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Month, Open Label Study of Extended Release Tacrolimus (Envarsus XR®, LCPT) With Mycophenolate, Rabbit Antithymocyte Globulin (rATG) and Early Steroid Withdrawal in de Novo Kidney Transplant Recipients
Lead sponsor
Simon Tremblay, PharmD, PhD
Phase
Phase 4
Overall status
Unknown status
Start date
June 21, 2019
Completion date
June 30, 2022
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, kidney transplantation